News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,571 Results
Type
Article (66685)
Company Profile (366)
Press Release (653520)
Section
Business (204869)
Career Advice (2638)
Deals (34027)
Drug Delivery (99)
Drug Development (84147)
Employer Resources (157)
FDA (16511)
Job Trends (14950)
News (346939)
Policy (32160)
Tag
Academia (2906)
Alliances (52796)
Alzheimer's disease (1390)
Approvals (16467)
Artificial intelligence (203)
Bankruptcy (311)
Best Places to Work (11733)
Biotechnology (252)
Breast cancer (226)
Cancer (1688)
Cardiovascular disease (133)
Career advice (2194)
CAR-T (122)
Cell therapy (359)
Clinical research (66892)
Collaboration (655)
Compensation (308)
COVID-19 (2779)
C-suite (153)
Data (1545)
Diabetes (199)
Diagnostics (6426)
Earnings (80060)
Employer resources (138)
Events (111404)
Executive appointments (539)
FDA (17353)
Funding (577)
Gene therapy (244)
GLP-1 (698)
Government (4423)
Healthcare (19165)
Infectious disease (2881)
Inflammatory bowel disease (125)
Interviews (474)
IPO (16088)
Job creations (3696)
Job search strategy (1873)
Layoffs (457)
Legal (7171)
Lung cancer (250)
Manufacturing (239)
Medical device (13483)
Medtech (13487)
Mergers & acquisitions (18289)
Metabolic disorders (550)
Neuroscience (1813)
NextGen: Class of 2025 (6682)
Non-profit (4684)
Northern California (1937)
Obesity (305)
Opinion (239)
Patents (143)
People (58514)
Phase I (20955)
Phase II (29365)
Phase III (21865)
Pipeline (658)
Postmarket research (2857)
Preclinical (9355)
Radiopharmaceuticals (261)
Rare diseases (317)
Real estate (6158)
Regulatory (22261)
Research institute (2612)
Resumes & cover letters (412)
Southern California (1689)
Startups (3834)
United States (17660)
Vaccines (670)
Weight loss (226)
Date
Today (13)
Last 7 days (653)
Last 30 days (2760)
Last 365 days (35919)
2025 (2798)
2024 (36481)
2023 (41302)
2022 (52622)
2021 (57036)
2020 (55223)
2019 (47672)
2018 (36070)
2017 (34211)
2016 (34030)
2015 (40211)
2014 (33448)
2013 (29521)
2012 (30296)
2011 (30507)
2010 (28798)
Location
Africa (971)
Arizona (175)
Asia (43211)
Australia (7555)
California (4486)
Canada (1595)
China (388)
Colorado (200)
Connecticut (222)
Europe (98798)
Florida (645)
Georgia (152)
Illinois (446)
Indiana (245)
Maryland (737)
Massachusetts (3517)
Michigan (202)
Minnesota (332)
New Jersey (1264)
New York (1278)
North Carolina (877)
Northern California (1937)
Ohio (171)
Pennsylvania (1014)
South America (1269)
Southern California (1689)
Texas (655)
Utah (132)
Washington State (459)
720,571 Results for "biomedical advanced research and development authority barda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
November 5, 2024
·
6 min read
Press Releases
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
January 29, 2025
·
8 min read
Decentralized trials
Walgreens, BARDA Team in $100M Partnership to Boost Decentralized Clinical Trials
The retail pharmacy giant and the Biomedical Advanced Research and Development Authority hope to make decentralized clinical trials more accessible and representative of the U.S. population.
August 20, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
Press Releases
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
Biotech Beach
Qpex Biopharma, a Shionogi Group Company, Receives an Additional $10M Award by BARDA as Part of Qpex’s Partnership to Advance its Portfolio of Antibiotics Addressing Drug-Resistant Infections
Qpex Biopharma, Inc. today announced the exercise of a $10 million option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, to support the advancement of the company’s antibiotic clinical development program.
May 30, 2024
·
5 min read
BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech, Inc. announced today that its first-in-class drug candidate has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for evaluation in a U.S. government-funded clinical study.
June 24, 2024
·
7 min read
Vaccines
Moderna to Produce Bird Flu Vaccine Under $176M BARDA Project Award
Moderna on Tuesday announced it has been awarded $176 million by a consortium funded by the Biomedical Advanced Research and Development Authority to develop an mRNA-based vaccine to counter H5N1 avian influenza.
July 2, 2024
·
2 min read
·
Tyler Patchen
Drug Development
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
InflaRx N.V. (Nasdaq: IFRX) announced today that GOHIBIC (vilobelimab) has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, as one of three investigational therapies to be assessed in a Phase 2 clinical platform study exploring potential new options for the treatment of acute respiratory distress syndrome (ARDS).
June 24, 2024
·
12 min read
Press Releases
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola
January 14, 2025
·
6 min read
1 of 72,058
Next
